Oticon Medical is pleased to announce that its Sentio System has been honored with the Hearing Technology Innovator Award™ in the category of Auditory Implants: Bone Conduction at the fifth…
Hackensack Meridian Health, New Jersey’s largest and most comprehensive health network, is set to launch HMH 24/7, an AI-driven solution designed to enhance primary care by seamlessly integrating virtual and…
Tempus AI, Inc. (NASDAQ: TEM), a leader in using AI for precision medicine, has announced that four of its abstracts have been accepted for the European Society for Medical Oncology…
Rising Pharmaceuticals, Inc. has announced the commercial launch of Edetate calcium disodium injection. Despite a current shortage of this product in the U.S., Rising’s version remains available. Rising Pharmaceuticals, Inc.…
As people age or experience life events like childbirth, maintaining pelvic muscle strength can be challenging. While Kegel exercises are a well-known solution, they are often overlooked. Developed by Dr.…
Results from the DESTINY-Breast12 phase 3b/4 trial reveal that ENHERTU® (trastuzumab deruxtecan) demonstrated significant clinical activity in HER2-positive metastatic breast cancer patients with brain metastases who had received up to…
Spencer Health Solutions (SHS), a leader in intelligent medication management technology, has announced its achievement of ISO 27001:2022 certification. This esteemed accreditation highlights SHS’s dedication to safeguarding patient data and…
Contraline, Inc., a clinical-stage biotechnology firm, has signed an exclusive option-to-license agreement with the Population Council for the Nestorone/Testosterone Transdermal Gel (NES/T) for male contraception. If the option is exercised,…
Paragon 28, Inc. (NYSE: FNA) is excited to introduce a new Right-Angle Drill for its APEX 3D™ Total Ankle Replacement System. This innovative tool is designed to enhance tibia preparation…
Following our April 8, 2024, announcement, we’re excited to provide an update on our progress. The U.S. Food and Drug Administration (FDA) approved a Phase I/II clinical trial for DFP-10917…
On the second day of the 11th Annual World Patient Safety, Science & Technology Summit, hosted by the Patient Safety Movement Foundation (PSMF) at UC Irvine, the focus was on…
Daiichi Sankyo Europe (Daiichi Sankyo) has announced an enhanced commitment to tackling significant gaps in cardiovascular care, focusing on disparities in treatment and outcomes among different patient groups. This renewed…
